Circulating insulin-like growth factor I in relation to melanoma risk in the European prospective investigation into cancer and nutrition.

MLA

Bradbury, Kathryn E., et al. “Circulating Insulin-like Growth Factor I in Relation to Melanoma Risk in the European Prospective Investigation into Cancer and Nutrition.” International Journal of Cancer, vol. 144, no. 5, Mar. 2019, pp. 957–66. EBSCOhost, https://doi.org/10.1002/ijc.31854.

APA

Bradbury, K. E., Appleby, P. N., Tipper, S. J., Travis, R. C., Allen, N. E., Kvaskoff, M., Overvad, K., Tjønneland, A., Halkjaer, J., Cervenka, I., Mahamat-Saleh, Y., Bonnet, F., Kaaks, R., Fortner, R. T., Boeing, H., Trichopoulou, A., La Vecchia, C., Stratigos, A. J., Palli, D., … Key, T. J. (2019). Circulating insulin-like growth factor I in relation to melanoma risk in the European prospective investigation into cancer and nutrition. International Journal of Cancer, 144(5), 957–966. https://doi.org/10.1002/ijc.31854

Chicago

Bradbury, Kathryn E, Paul N Appleby, Sarah J Tipper, Ruth C Travis, Naomi E Allen, Marina Kvaskoff, Kim Overvad, et al. 2019. “Circulating Insulin-like Growth Factor I in Relation to Melanoma Risk in the European Prospective Investigation into Cancer and Nutrition.” International Journal of Cancer 144 (5): 957–66. doi:10.1002/ijc.31854.